110 related articles for article (PubMed ID: 21734006)
1. Management of recurrent/persistent papillary thyroid carcinoma: efficacy of the surgical option.
Schuff KG
J Clin Endocrinol Metab; 2011 Jul; 96(7):2038-9. PubMed ID: 21734006
[No Abstract] [Full Text] [Related]
2. [Papillary microcarcinoma of the thyroid gland].
Soliman T
Wien Klin Wochenschr; 1993; 105(20):591-4. PubMed ID: 8259688
[No Abstract] [Full Text] [Related]
3. Papillary thyroid cancer with unusually aggressive behaviour. Case report.
Di Saverio G; Bergamaschi R; Manunta A
Acta Chir Scand; 1989; 155(1):57-8. PubMed ID: 2929206
[TBL] [Abstract][Full Text] [Related]
4. Central compartment dissection in thyroid papillary carcinoma.
Forest VI; Clark JR; Ebrahimi A; Cho EA; Sneddon L; Gao K; O'brien CJ
Ann Surg; 2011 Jan; 253(1):123-30. PubMed ID: 21135696
[TBL] [Abstract][Full Text] [Related]
5. Thyroid follicular epithelial cell-derived carcinomas: an overview of the pathology of primary and recurrent disease.
Todd WU; Wenig BM
Otolaryngol Clin North Am; 2008 Dec; 41(6):1079-94, vii-viii. PubMed ID: 19040970
[TBL] [Abstract][Full Text] [Related]
6. Papillary thyroid microcarcinoma outcomes and implications for treatment.
Pearce EN; Braverman LE
J Clin Endocrinol Metab; 2004 Aug; 89(8):3710-2. PubMed ID: 15292294
[No Abstract] [Full Text] [Related]
7. Localization of recurrent thyroid cancer: a technical challenge.
Shaha AR
Ann Otol Rhinol Laryngol; 2009 Jul; 118(7):479-80. PubMed ID: 19708484
[No Abstract] [Full Text] [Related]
8. [Risk factors in papillary thyroid cancer].
Wagner HE; Birrer A; Lüscher B; Kinser J; Rösler H
Helv Chir Acta; 1993 Jun; 59(5-6):819-23. PubMed ID: 8376147
[TBL] [Abstract][Full Text] [Related]
9. [Surgical treatment of recurrent thyroid carcinoma after primary resection].
Kohara N; Furui J; Tomioka T; Motojima K; Tsunoda T; Kanematsu T
Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):847-52. PubMed ID: 8377761
[TBL] [Abstract][Full Text] [Related]
10. [Anaplastic transformation of papillary carcinoma of the thyroid].
Gál I; Hatházi L; Nemes Z; Solymosi T
Orv Hetil; 1994 Mar; 135(11):581-4. PubMed ID: 8159411
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer.
Schuff KG; Weber SM; Givi B; Samuels MH; Andersen PE; Cohen JI
Laryngoscope; 2008 May; 118(5):768-75. PubMed ID: 18197134
[TBL] [Abstract][Full Text] [Related]
12. Prognosis after reoperation for local recurrence of papillary thyroid carcinoma.
Uruno T; Miyauchi A; Shimizu K; Nakano K; Takamura Y; Ito Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K
Surg Today; 2004; 34(11):891-5. PubMed ID: 15526121
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis.
Zetoune T; Keutgen X; Buitrago D; Aldailami H; Shao H; Mazumdar M; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2010 Dec; 17(12):3287-93. PubMed ID: 20596784
[TBL] [Abstract][Full Text] [Related]
14. Papillary carcinoma of the thyroid, pathological aspects in relation to surgical management.
Tawfik HN; El-Sayed Ahmed L; El-Said A
J Egypt Med Assoc; 1976; 59(5-6):449-67. PubMed ID: 1032314
[No Abstract] [Full Text] [Related]
15. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
16. [Unifocal autonomy and carcinoma of the thyroid gland].
Emmrich P; Gauer J; Mättig H
Zentralbl Chir; 2001 Sep; 126(9):672-5. PubMed ID: 11699281
[TBL] [Abstract][Full Text] [Related]
17. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.
Kim MK; Mandel SH; Baloch Z; Livolsi VA; Langer JE; Didonato L; Fish S; Weber RS
Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1214-6. PubMed ID: 15492172
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the prognostic significance of lymph node related characteristics in papillary thyroid carcinoma patients presenting with pre- or intra-operative evidence of cervical lymph node metastases.
Soudry E; Hilly O; Preis M; Hadar T; Segal K; Bachar G; Feinmesser R
J Laryngol Otol; 2014 Mar; 128(3):284-8. PubMed ID: 24636046
[TBL] [Abstract][Full Text] [Related]
19. Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited.
Doi SA; Woodhouse NJ; Thalib L; Onitilo A
Clin Med Res; 2007 Jun; 5(2):87-90. PubMed ID: 17607042
[No Abstract] [Full Text] [Related]
20. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
